Cinnamon Peach Smoothie

 

For general guidelines on preparing smoothies and shakes, see our Tips for Easy Smoothie Making.

Preparation time: 10 minutes.

Serves one.

Ingredients

  • 1 cup diced peaches (fresh, frozen or canned)
  • ½ cup low-fat plain yogurt
  • ½ cup any liquid (milk, soy milk, rice milk, Boost, Ensure, Boost Plus, or Ensure Plus, or a generic version of one of these products); use more than ½ cup if needed to blend
    1 tablespoon honey
  • Cinnamon to taste (1/8 teaspoon is a good place to start)

Instructions

  • Clean, peel, and prepare the fruit and place in the blender.
  • Add liquid ingredients to blender.
  • Blend all of the ingredients together to your desired consistency.
  • Add additional liquid to the blender if needed to thin out consistency for better blending. Depending on the strength of your blender, you may need more or less liquid to make the mixture blend.

Per serving*: 390 calories; 68 grams of carbohydrates; 15 grams of protein; 6.5 grams of fat; 2.5 grams of fiber; 215 milligrams of sodium; 866 milligrams of potassium

* Made with Boost Plus, Ensure Plus, or a generic version of one of these products. Calories and protein will be somewhat lower if made with milk, soy milk, rice milk, or another liquid.

If you are feeling good and eating well, you may not need high calorie eating tips and recipes. Instead, you can try our recipes in the Wellness Nutrition area.

Latest Cancer News
Rectal Cancer Increasing in People Under 40

September 2, 2010 — Although still relatively uncommon in young people, the incidence of rectal cancer appears to be increasing in this population. These results were published in the journal Cancer.

Early Palliative Care Linked with Longer Lung Cancer Survival

September 1, 2010 — Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the addition of early palliative care to standard cancer treatment resulted in better quality of life and mood and longer survival than standard treatment alone. These results were published in the New England Journal of Medicine.

Istodax Active against Refractory Cutaneous T-cell Lymphoma

August 31, 2010 — Final results from a Phase II clinical trial provide additional evidence that Istodax® (romidepsin) is active against refractory cutaneous T-cell lymphoma. These results were published in the Journal of Clinical Oncology.

Select news items provided by Reuters Health